bioRxivNeurosciencePreprint
Modeling Alzheimer's Disease with APOE4 Neuron-Glial Brain Assembloids Reveals IGFBPs as Therapeutic Targets
Eliana Sherman, Kevin QiuiD, Rebecca Roberts, Lucille Shichman, Sihan LiiD, Huayu SuniD, Lucie Ide, Allison Tucker, Seonjoo LeeiD, Weronika GniadzikiD, Jung Bum Shin, Katia Sol‐Church, Jaideep KapuriD, Aiying ZhangiD, Alev ErişiriD, Lulu JiangiD, the Alzheimer’s Disease Neuroimaging Initiative
- Citations
- 0
Abstract
Alzheimers disease (AD) research has been hindered by the lack of models that faithfully recapitulate the full profile of disease progression in a human genetic background. We developed a 3D assembloid model ("Masteroid") using iPSC-derived neurons, astrocytes, and microglia from APOE4/4 and isogenic control lines. Neurons were seeded with tau oligomers, then combined with astrocytes and microglia to form mature 3D Masteroids, followed by amyloid-{beta} oligomer exposure. After four weeks, AD-Masteroids exhibited hallmark pathologies, including extracellular amyloid-{beta} deposits, intracellular tau aggregation, neurodegeneration, astrogliosis, and microglial activation, with APOE4 exacerbating all phenotypes. Single-cell RNA sequencing further identified novel roles of IGFBP pathways in amyloid-{beta} and tau-mediated pathology. This innovative platform provides a robust system to dissect cellular and molecular mechanisms of AD progression and offers a powerful tool for therapeutic discovery. HighlightsO_LIThe 3D human neuron-glia assembloid ("Masteroid"), composed of neurons, astrocytes, microglia, and oligodendrocytes, faithfully recapitulates human brain ultrastructure and intercellular interactions. C_LIO_LIExposure to oligomeric tau and A{beta} induced hallmark Alzheimers pathologies, including amyloid deposition, tau aggregation, neurodegeneration, and gliosis. C_LIO_LIThe APOE4 genotype exacerbated all pathological features, highlighting its role in driving multicellular interactions that accelerate disease progression. C_LIO_LIThe IGF signaling axis was identified as a key mediator of A{beta}- and tau-induced pathology and a potential therapeutic target. C_LI Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=183 SRC="FIGDIR/small/683162v1_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@f91740org.highwire.dtl.DTLVardef@165726eorg.highwire.dtl.DTLVardef@13b957forg.highwire.dtl.DTLVardef@d40307_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis
Stefan Wendt, Ada J. Lin, … Haakon B. Nygaard·Journal of NeuroinflammationPeer-reviewed·Apr 24, 2025
- Microglia Depletion Reduces Human Neuronal APOE4-Driven Pathologies in a Chimeric Alzheimer's Disease Model
Antara T. Rao, Nuo Chen, … Yadong Huang·bioRxiv·Nov 10, 2023
- Divergent Effects of APOE3 and APOE4 Human Astrocytes on Key Alzheimer's Disease Hallmarks in Chimeric Mice
Joan Cruz-Sesé, Marta Miron-Alcala, … Amaia M. Arranz·bioRxiv·Jan 28, 2025
- Engineered 3D Immuno-Glial-Neurovascular Human miBrain Model
Alice E. Stanton, Adele Bubnys, … Li‐Huei Tsai·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 17, 2025
- APOE4-Aβ synergy drives brain network dysfunction and neuronal lysosomal-ER proteostasis dysregulation in preclinical Alzheimer's disease
Jia Shin, Erica S Brady, … Jorge J. Palop·bioRxiv·Nov 11, 2025
- Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer's disease mouse model
Jessica R. Blumenfeld, Yaqiao Li, … Yadong Huang·bioRxiv·Nov 25, 2025